Transdermal administration of apomorphine
Patent 5562917 Issued on October 8, 1996. Estimated Expiration Date: 
December 23, 2014. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
December 23, 2014. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesInventorsAssigneeApplicationNo. 362831 filed on 12/23/1994US Classes:424/447, Bandages with incorporated medicaments424/448, Pressure sensitive adhesive means514/944GELExaminersPrimary: Phelan, D. GabrielleAttorney, Agent or FirmInternational ClassA61L 015/00AbstractDosage forms for the transdermal administration of apomorphine are described. The dosage forms are water-soluble gel compositions that contain apomorphine, optionally together with a permeation enhancer, or transdermal patches.Other References
| |
